These data indicate that up-regulation of PD-L1 and FOXP3 in PBMCs may be a result of adaptive resistance to T cells and their expression is regulated by IFN-γ levels in the breast cancer microenvironment. The gene discussed is CD274; the disease is breast carcinoma.